Adiponectin may influence cancer risk through its well-recognized effects on insulin resistance, but it is also plausible that adiponectin acts on tumor cells directly (Yamauchi et al., 2001; Barb et al., 2007). This evidence concerns the gene ADIPOQ and Insulin resistance.